GlassScriptPhysician profile
Byron B Tarbox
NPI 1629061205
$10,924.18
in general payments reported to CMS, 2019-2025
11 companies · $1,906 in 2025
The $1,906 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,612 · 2020: $461 · 2021: $17.71 · 2022: $1,225 · 2024: $1,702 · 2025: $1,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,876 · Food and Beverage: $427 · Consulting Fee: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,876.44 |
| Food and Beverage | $426.75 |
| Consulting Fee | $305.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $6,548.07 | 2019-2025 | |
| Arthrex, INC. | $3,733.59 | 2019-2025 | |
| Hikma Pharmaceuticals USA | $305.33 | 2024 | Combogesic IV |
| Depuy Synthes Sales INC. | $86.43 | 2019-2024 | Monovisc |
| Stryker Corporation | $57.74 | 2020 | |
| Cardinal Health 200 LLC | $44.22 | 2019-2024 | |
| Pacira Therapeutics, INC. | $40.43 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $39.34 | 2019-2022 | |
| Smith+Nephew, INC. | $25.81 | 2025 | Journey II, Tandem |
| Vertex Pharmaceuticals Incorporated | $25.51 | 2025 | |
| Organogenesis INC. | $17.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Byron Tarbox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.